Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-126701
Filing Date
2021-04-22
Accepted
2021-04-22 16:08:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d887358ddefa14a.htm DEFA14A 18880
2 GRAPHIC g887358s3.jpg GRAPHIC 117087
3 GRAPHIC g887358s4.jpg GRAPHIC 36326
  Complete submission text file 0001193125-21-126701.txt   231056
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38276 | Film No.: 21844883
SIC: 2834 Pharmaceutical Preparations